| Wed, Nov 11, 2009 | | • | CELLDEX THERAPEUTICS, INC. Financials
EDGAR Online Financials (Wed, Nov 11)
| | Fri, Nov 6, 2009 | | • | CELLDEX THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009
Business Wire (Thu, Nov 5)
| | • | New Star Analyst Rankings for Celldex Therapeutics, Inc
StarMine (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Wed, Nov 4)
| | • | Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
Business Wire (Wed, Nov 4)
| | Thu, Oct 29, 2009 | | • | Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of Antibody-Based Cancer Vaccine Candidate, CDX-1307
Business Wire (Thu, Oct 29)
| | Wed, Oct 28, 2009 | | • | ImmunoCellular's Promising Brain Cancer Vaccine
at Seeking Alpha (Wed, Oct 28)
| | Wed, Oct 21, 2009 | | • | CELLDEX THERAPEUTICS, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statem
EDGAR Online (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Celldex Therapeutics: Plenty of Cash, Pending Clinical Catalysts
at Seeking Alpha (Tue, Oct 20)
| | Wed, Oct 14, 2009 | | • | Incyte: Life After Debt (Part I)
at Seeking Alpha (Wed, Oct 14)
| | Fri, Oct 2, 2009 | | • | CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition
EDGAR Online (Fri, Oct 2)
| | Thu, Oct 1, 2009 | | • | Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation
Business Wire (Thu, Oct 1)
| | Wed, Sep 30, 2009 | | • | Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation
Business Wire (Wed, Sep 30)
| | Tue, Sep 29, 2009 | | • | Coverage initiated on Celldex Therapeutics by WBB Securities
Briefing.com (Tue, Sep 29)
| | Tue, Sep 22, 2009 | | • | StockPreacher.com Issues Trading Outlook for CEL-SCI Corp
GlobeNewswire (Tue, Sep 22)
| | Mon, Sep 14, 2009 | | • | Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate
Business Wire (Mon, Sep 14)
| | Wed, Sep 9, 2009 | | • | Second Quarter Report for Celldex Therapeutics, Inc.
WILink (Wed, Sep 9)
| | Fri, Sep 4, 2009 | | • | CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Other Events
EDGAR Online (Fri, Sep 4)
| | • | Celldex Therapeutics Announces Appointment of Larry Ellberger as Chairman of the Board
Business Wire (Fri, Sep 4)
|
Add CLDX News to My Yahoo!:
 
| |
|
0.34% Nasdaq 
0.04 (0.88%) 
Headlines
